Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
- 22 November 2021
- journal article
- editorial
- Published by Elsevier in The Lancet Rheumatology
- Vol. 4 (2) , e80-e82
Abstract
No abstract availableAll Related Versions
This publication has 9 references indexed in Scilit:
- Inactivated vaccines may not provide adequate protection in immunosuppressed patients with rheumatic diseasesAnnals of the Rheumatic Diseases, 2022
- Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workersNature Communications, 2021
- Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individualsInternational Journal of Infectious Diseases, 2021
- Hybrid immunityScience, 2021
- Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic diseaseClinical Rheumatology, 2021
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA VaccineNew England Journal of Medicine, 2021
- Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2Nature Medicine, 2021
- Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021Eurosurveillance, 2021
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised HostNew England Journal of Medicine, 2020